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ABSTRACT 
Background: Age is a major risk factor in developing heart diseases and has been associated 
with  profound  transcriptional  changes  in  mammalian  tissues.  Low  tissue  selenium  has 
recently been linked to several age-related diseases, including cardiovascular disease. This 
study investigated the global effects of age and dietary supplementation of selenium on heart 
transcriptional profiles in POLG mutator mice.  
Methods:  Heart  transcription  profiles  from  young  (2-month-old)  and  old  (13-month-old) 
animals fed either a control diet or a diet supplemented with 1.0 mg selenium from selenium-
enriched yeast (SP)/kg diet were obtained and validated using microarray and real-time RT-
PCR techniques.  
Results: Aging led to significant transcriptional changes, where the expression of 1942 genes 
in old animals was changed by a fold change larger than 2.0, when compared to  young 
animals.  Age-regulated  genes  are  associated  with  cardiovascular  system  development, 
immune and inflammatory response, and cellular oxidative stress response. Multiple genes 
linked with cardiomyocyte apoptosis, hypertrophy, and cardiac fibrosis, such as Myh7, Lcn2, 
Spp1, and Serpine1, were significantly up-regulated in old animals. SP supplementation also 
caused significant transcriptional changes in the heart, especially in old mice where many 
age-dependent transcriptional changes were totally or partially reversed by SP. Upstream 
regulator  analysis  further  indicated  that  genes  for  Foxo1  and  Foxo3,  two  transcriptional 
regulators  involved  in  the  regulation  of  cardiac  muscle  remodeling,  were  significantly 
activated by SP, suggesting that Foxo-mediated transcriptional activities play important roles 
in the anti-aging properties of SP.  Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 99 of 119 
Conclusions: Results of this study indicate that SP supplementation attenuated age-related 
transcriptional changes in the heart of old POLG mice, which implies a potential clinical 
application of dietary selenium in preventing decline of cardiac function in old animals.   
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BACKGROUND: 
In humans and rodents, heart aging is characterized by a loss of myocytes (cardiomyopathy), 
enlargement of the remaining myocytes (hypertrophy), and cardiac fibrosis [1-3].  At the 
molecular level, aging has been associated with widespread transcriptional changes in the 
heart,  where  transcriptional  profiles  associated  with  aging  have  been  characterized  by  a 
metabolic shift toward carbohydrate metabolism, induction of genes having structural roles, 
and reduced protein synthesis [4, 5].  It has also been associated with the impairment of the 
transcriptional responses to oxidative stress, as indicated by diminished induction of stress 
response genes and lower constitutive expression levels of antioxidant genes [5, 6]. Aging of 
the heart has also been related to down-regulation of genes involved in energy metabolism, 
particularly mitochondrial genes [7].  
Aging related changes are modifiable. Recent studies comparing 30-month-old control 
and calorie-restricted (CR) mice showed that age-related changes in gene expression could be 
remarkably prevented, and that CR mice appeared to be biologically younger than animals 
receiving the control diet [5, 8]. Studies have also demonstrated that moderate CR (65% feed 
intake of ad libitum) in rats reduced the progression of cardiomyopathy [9], while lifelong 
CR prevented age-related impairments of late diastolic function in B6D2F1 mice [10]. The 
mechanisms leading to age-related alterations, however, are not well understood, although it 
is extensively accepted that increased oxidative stress contributes to myocardial dysfunction 
with advancing age [11, 12]. Previous studies indicated that several natural and synthetic 
compounds  with  antioxidant  activity,  including  α-lipoic  acid  (LA),  resveratrol  (RE), 
coenzyme Q10 (CQ) and vitamin E (VE), contain the potential to slow down certain specific 
aspects related with aging [5]. For example, it has been shown that dietary supplementation 
with LA or CQ inhibited gene expression changes which are linked with the extracellular 
matrix, cellular structure, and protein turnover in aged mice [13]; while RE, a polyphenol 
compound found in red wine, has been reported to delay cardiac aging in mice [14, 15] and 
increase the survival of mice fed a high fat diet [16]. VE supplementation was reportedly 
effective in inhibiting the expression of genes associated with cardiomyocyte hypertrophy 
and increased innate immunity [17].  
Selenium (Se) has long been associated with defense against oxidative stress. Lower 
tissue  Se  status  has  been  linked  to  an  increased  risk  of  several  aging-related  diseases, 
including cardiovascular diseases [18, 19]. Several animal studies have also demonstrated the 
cardiovascular  benefits  of  Se,  whereby  dietary  Se  supplementation  prior  to  ischemia-
reperfusion injury resulted in improved cardiac functional recovery, reduced incidence of 
reperfusion  arrhythmias,  and  preservation  of  ventricular  ultra-structure  [20-22].  At  a 
transcriptional level, the effect of Se supplementation on heart aging has not been reported.  Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 100 of 119 
In this study, we investigated the effects of dietary supplementation of Sel-Plex
® (Alltech, 
Nicholasville, KY), a natural organic Se source derived from selenium-enriched yeast, on the 
cardiac  transcriptional  profiles  of  young  and  old  animals,  and  evaluated  its  potential 
interventive effects on heart aging. POLG (proof reading-deficient mutation of polymerase 
gamma) mutator mice, an animal model of aging, were used in this study [23, 24]. POLG 
mice start to show significant premature aging phenotypes such as greying, osteoporosis, 
sarcopenia, and enlarged hearts as early as 7 - 9 months of age [25], and demonstrate marked 
cardiac  hypertrophy  and  dilatation,  impairment  of  systolic  and  diastolic  function,  and 
increased cardiac fibrosis  [25].   We found age-dependent  cardiac  transcriptional  changes 
such as increased expression of genes related to cellular immune and inflammatory response, 
cell death, as well as genes related with development of cardiomyocyte hypertrophy and 
fibrosis were partially reversed  by SP. This suggests a potential clinical application of Se in 
preventing or delaying the decline of cardiac function in the aging population.   
 
MATERIALS AND METHODS: 
Animals and diets. The POLG (PolgA
D257A  ⁄  D257A) mice were provided by Dr.Tomas A. 
Prolla (University of Wisconsin, Madison). Immediately after weaning at 21 days (PND21), 
male mice were randomly assigned to a selenium-deficient diet (SD) or a diet supplemented 
with  1 mg selenium/kg diet (SP) using  selenium-enriched  yeast  (Sel-Plex
®, Alltech  Inc., 
Nicholasville, KY). Experimental diets were prepared by Harlan-Teklad (Madison, WI) and 
have been described in detail elsewhere [26]. To control the effects of non-selenium-related 
yeast components, the SD diet was supplemented with an equal amount of non-selenium 
enriched yeast (selenium < 0.5 ppm on a product basis). Selenium levels in dietary premixes 
were evaluated by atomic absorption spectroscopy [27]. The selenium concentration in the 
SD diet was confirmed to be < 0.03 ppm, whereas in the supplemented diet it was 1.05 ppm. 
Mice were housed two to three per cage, and food and water were provided ad libitum. At 60 
days  of  age,  a  total  of  20  mice,  10  each  from  SD  and  SP  were  euthanized  by  cervical 
dislocation, and the hearts were rapidly dissected, flash-frozen in liquid nitrogen, and stored 
at -80ºC. At 400 days of age, another set of 20 animals (10 animals from each diet group) 
were euthanized for sample collection. All procedures were approved by the Animal Care 
Committee at the William S. Middleton Veterans Administration Hospital. 
Tissue selenium quantification. To evaluate the effects of selenium supplementation on the 
tissue mineral contents, liver selenium was measured using the method adapted from Gerber 
et al   [28], with slight modifications. Weighted liver samples (25 to 45 mg) were placed in 
MARSXpress digestion vessels containing 2ml of 69% OPTIMA grade nitric acid (Fisher 
Scientific, NJ, USA) and 2ml of 30% (w/w) hydrogen peroxide solution (Sigma Aldrich, St. 
Louis, MO). The samples were then digested using the MARS 5 microwave digestion system 
(CEM Corporation, Matthews, NC) under the following conditions:  ramp to 200°C for 20 
min at 1200W, then held at this temperature for another 20 min before cooling down for 15 
min. Digested samples were diluted to 50ml using 18.2MΩ/cm deionized water and then 
used for selenium analysis on Agilent 7700 series ICP-MS instrument (Agilent Technologies, 
Inc., Japan).  Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 101 of 119 
Total RNA extraction. Approximately 30 mg of left ventricle tissue was homogenized with 
a  Qiagen  TissueRuptor  (Qiagen,  Valencia,  CA)  and  total  RNA  was  extracted  using  an 
RNeasy Mini kit (Qiagen), following the protocol recommended by the company. To remove 
contaminating  DNA,  on-column  DNA  digestion  with  RNase-Free  DNase  (Qiagen)  was 
performed. Integrity and purity of isolated RNA was assessed using a NanoDrop ND-1000 
spectrophotometer  (Thermo  Scientific,  Wilmington,  DE)  and  further  confirmed  with  an 
Agilent 2100 Bioanalyzer System (Agilent Technologies, Santa Clara, CA). 
Microarray procedures. cRNA preparation, hybridization, and scanning were performed 
following the standard protocols recommended by Affymetrix (Santa Clara, CA). Briefly, 
purified RNA was used for biotin-labeled cRNA synthesis using the Affymetrix GeneChip 
Expression 3’-Amplification One-Cycle Target Labeling Kit (Affymetrix), according to the 
manufacturer’s recommended procedures. Labeled cRNA was hybridized to mouse genome 
MG-430_2.0  GeneChip  arrays    (Affymetrix)  for  16  h  at  45ºC,  followed  by  washing,  
streptavidin-phycoerythrin (SAPE) staining,  and finally scanning in an GeneChip Scanner 
3000 7G (Affymetrix). Probe signal intensities were analyzed using an Affymetrix
 MAS5 
algorithm scaled to the default trimmed mean signal intensity (SI) of 500.  A total of 24 gene 
expression profiles, six each from SD-young, SD-old, SP-young, and SP-old animals were 
obtained.  
Microarray  data  analysis.  GeneSpring  GX  12.5  (Agilent)  was  used  to  validate  and 
normalize microarray data and to perform statistical and gene expression pattern analyses. 
Briefly, normalization was done by first scaling the intensity of probesets of the arrays to a 
mean target intensity of 500, followed by baseline transformation to median of all samples. 
Background corrections were done by MAS5 based on the Perfect Match (PM) and Mis-
Match (MM) probe design of the microarray.  To minimize the possibility of misleading 
findings, probe sets with low signal intensity and those which were labeled as ‘Absent’ by 
the MAS5 algorithm across samples were excluded from further analysis.  The differentially 
expressed genes by age or diets were filtered using the volcano plot method where genes 
with P < 0.05 and corresponding signal intensity fold change (FC) > 1.2 or FC < -1.2 were 
deemed to be significantly different. 
Pathway  analysis  of  microarray  data.  To  dissect  the  biological  themes  represented  by 
altered  transcription  profiles  by  diet  and  age,  two  independent  pathway  analyses  were 
applied.  First,  we  performed  parametric  analysis  of  gene  set  enrichment  (PAGE),  a 
computational method that allows determination of significant changes in a defined gene set 
[29].    To  identify  functional  clusters  that  characterize  the  transcriptional  alterations 
associated with aging or dietary Se status, significantly changed genes by aging or diet were 
further grouped into networks, functions and canonical pathways using Ingenuity Pathways 
Analysis software (IPA, Ingenuity Systems, Redwood City, CA). Fischer's exact test was 
used  to  determine  the  significance  of  the  association  between  the  genes  and  the  given 
network, biological function or canonical pathway. Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 102 of 119 
Real-time quantitative-PCR confirmation. For validation of the effects of diet and age on 
gene  expression,  a  subset  of  differentially  regulated  genes  were  selected  for  further 
confirmation based on the function of interest using real-time quantitative PCR (RT-qPCR) 
analysis.  The same  RNA used for microarray  analysis  was  also  employed for RT-qPCR 
analysis. Each sample of total RNA (0.5 μg) was reverse transcribed into cDNA using the 
High  Capacity  cDNA  Reverse  Transcription  kit  (Applied  Biosystems,  Foster  City,  CA), 
according to the manufacturer’s instructions. RT-qPCR was performed in triplicate using 
Taqman
®  probes  and Taqman
®  fast  advanced  master mix (Applied Biosystems),  and the 
7500 Real-time PCR FAST system (Applied Biosystems).  Taqman
® probes (Table 1) were 
pre-designed by Life Technologies.  The relative quantification (RQ) was calculated as a 
ratio of the target gene to control gene using the delta-delta Ct (ΔΔCt) method. Conditions 
for RT-qPCR were as follows: 95°C for 20s, followed by 40 cycles of 95°C for 3s and 60°C 
for 30s. RT-qPCR results were analyzed using a Student’s t-test.  Values are presented as 
means ± SEM, and differences between treatment means were considered significant at P < 
0.05.  
Table 1: Primers used in RT-qPCR 
Taqman
® Probe ID
*  Gene Symbol  Gene Title 
Mm01335356_g1  Selh  Selenoprotein H 
Mm00447333_m1  Snca  Synuclein, alpha 
Mm00656767_g1  Gpx1  Glutathione peroxidase 1 
Mm00435860_m1  Serpine1 
Serine  (or  cysteine)  peptidase  inhibitor,  clade  E, 
member 1 
Mm00809552_s1  Lcn2  Lipocalin 2 
Mm00600555_m1  Myh7  Myosin, heavy polypeptide 7, cardiac muscle, beta 
Mm01611440_m1  Spp1  Secreted phosphoprotein 1 
Mm01341361_m1  Timp1  Tissue Inhibitor of metalloproteinase 1 
Mm00491305_m1  Trim54  Tripartite motif-containing 54 
Mm00477771_m1  Nf2
^  Neurofibromatosis 2 
* Primers were pre-designed by Life Technologies (Carlsbad, CA).  
^ Nf2 was used as reference gene to account for non-biological variations. 
 
Western blot analysis. Ventricular tissue samples from the same source material used in the 
microarray analysis were homogenized in cold lysis buffer (1.5 mM KCl, 50 mM Tris HCl, 
0.125% sodium deoxycholate, 0.375% Triton X 100, 0.15% NP40, 3 mM EDTA) containing 
one tablet of Pierce protease and phosphatase inhibitor mini tablets on ice. The supernatant 
was subsequently collected and protein concentration was determined using a BCA assay 
(Pierce BCA Protein Assay Kit; Thermo Scientific, Rockford, IL). Total protein (25µg) was 
separated  on  a  12%  Agarose  gel  and  transferred  to  PVDF  2μm  membrane  (BIO-RAD). 
Membranes  were  incubated  with  primary  antibodies  for  2  h  at  room  temperature.  The 
primary antibody of MYH7 was purchased from Santa Cruz, while ACTB (LI-COR, Lincoln, 
NE) was used as an internal control for quantification. Positive signals on the membrane 
blots  were  detected  using  Amersham’s  enhanced  chemiluminescence  Western  Blotting Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 103 of 119 
Detection  reagents  (GE  Healthcare  Life  Sciences)  or  fluorescent-labeled  secondary 
antibodies (LI-COR, Lincoln, NE).  
 
RESULTS: 
Dietary  effects  on  the  liver  Se  concentration.  To  confirm  the  effects  of  Se 
supplementation, liver Se content was measured.  As expected, liver Se concentration was 
significantly increased (P<0.01) in animals fed the SP supplemented diet when compared 
with animals fed the SD diet in both young (1771.6 ± 260.3 ppb vs. 318.1 ±26.1 ppb) and old 
animals (1778.5 ± 48.7 ppb vs. 139.23 ± 47.1 ppb).   
Overview  of  aging-regulated  gene  expression  patterns  of  POLG  mutator  mice. 
Clustering of gene expression profiles of animals fed with control diet indicated a dramatic 
difference on overall cardiac transcription profiles between young and old animals, as shown 
in Figure 1A, where expression profiles of old animals were clearly separated from those of 
young animals. Further comparison indicated that expression of 6830 genes in the heart were 
significantly different (P<0.05, FC >1.2 or FC <-1.2) between young and old mice. Among 
these, 1942 genes had an increased FC >2.0 or a decreased FC < -2.0 (Figure 1B). Details of 
these highly age-regulated genes are shown in supplemental table 1.  
 
Figure 1. Effects of age on cardiac transcription profiles. A) Unsupervised hierarchical clustering of 
the expression profiles from old and young animals fed the control diet.  In the heatmap, normalized gene 
expression values are shown in colors that reflect the expression changes compared to the mean value of each 
gene, where blue, red or yellow colors represent decreased, increased or no change in the level of expression 
intensity,  respectively.  The  dendrogram  on  the  top  reflects  the  extent  of  similarity  of  expression  profiles 
between  arrays,  while  the  dendrogram  on  the  left  side  represents  the  changes  of  expression  patterns  of 
individual genes across the array. B) Volcano plot of age-regulated genes. 1943 genes that significantly altered 
by age (P<0.05, FC >2.0 or FC <-2.0) shown as red dots in the picture.   
      To  minimize  the  noise  associated  with  the  large  dataset,  as  well  as  to  focus  on  the 
biological processes represented by the most significantly altered genes, functional analysis 
was based on the above1942 highly age-regulated genes. Results indicated that functional Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 104 of 119 
classes associated with age-regulated genes are primarily involved in development of the 
cardiovascular  system,  immune  and  inflammatory  response,  tissue  development  and 
morphology, lipid metabolism and apoptosis (Figure 2A, supplemental table 2). Heart aging 
is generally related to the activation of these functions, which are indicated by the red squares 
in  the  green  frames  (Figure  2A).  Canonical  pathway  analysis  also  suggested  a  strong 
connection between aging and pathways important in immune and inflammatory response, 
such  as  IL-8  signaling,  clathrin-mediated  endocytosis  signaling,  acute  phase  response 
signaling,  Fcγ  receptor-mediated  phagocytosis  in  macrophages  and  monocytes,  NF-κB 
activation, and complement system (Figure 2B).   Figure 2
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Figure  2.  Aging  associated  biological  functions  and  canonical  pathways  in  the  hearts.  A) 
Biological functions associated to aging-regulated transcriptional changes. The significance of the biological 
functions to age-regulated genes was predicted based on Z-score (A positive score indicates an increase (red) in 
function while a negative z-score represent a suppressed (blue) function. Z-scores > 2 or < -2 were deemed to be 
significant and those functions are shown in green frames. B) Canonical pathways associated with age-regulated 
genes. The bar graph shows the significance of each age-associated pathway; line-connected dots represent the 
ratios of aging regulated genes to the total number of genes that make up that pathway. Significance was 
calculated based on Fischer's exact test.  
 
This is consistent with previous reports that aging and age-related diseases are linked to 
a chronic inflammatory state, including local infiltration of inflammatory cells and higher 
circulatory levels of pro-inflammatory cytokines, complement components, and cell adhesion Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 105 of 119 
molecules  [30,  31]  .  Aging  is  also  related  to  pathways  involved  in  oxidative  response, 
cellular maintenance, cellular morphology, DNA replication, apoptosis, protein degradation 
as  well  as  others  (Figure  2B).  Since  aging  of  the  heart  is  frequently  associated  with 
cardiomyopathy, hypertrophy, and cardiac fibrosis [2], we examined the influence of aging 
on genes that had functionally been related to development of cardiomyocyte apoptosis, heart 
hypertrophy, and fibrosis. As shown in table 2, aging has a dramatic impact on expression of 
these genes as judged by the number of gene expression changes and the large FCs. For 
example, lipocalin 2 (Lcn2) is an adipose-derived cytokine that plays an important role in 
cardiomyocyte apoptosis. Its expression level was increased more than 30 times (FC = 31.8) 
in  old  animals  compared  with  young  animals.  Similarly,  several  other  well  known  gene 
biomarkers that have been related to cardiovascular diseases, such as Spp1, Myh7, Mmp3, 
and Serpine1, were also significantly up-regulated by aging (Table 2). 
 
Table 2. Aging regulated genes that are functionally related to cardiomyocyte apoptosis, hypertrophy 
and fibrosis
 * 
Gene  FC _Age 
a   Function 
associations 
a  
Gene name 
TXNIP  2.425   AP  Thioredoxin interacting protein 
MMP2  2.487   AP  Matrix metallopeptidase 2  
MTOR  2.227   AP  Mechanistic target of rapamycin  
PLA2G5  -2.543   AP  Phospholipase A2, group V 
BCL2L1  2.001   AP  BCL2-like 1 
NFKBIB  3.584   AP  Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor, beta 
BNIP3  2.033   AP  BCL2/adenovirus E1B 19kDa interacting protein 3 
CAMK2D  -2.384   AP  Calcium/calmodulin-dependent protein kinase II delta 
ADRB1  -3.072   AP  Adrenoceptor beta 1 
LCN2  31.838   AP  Lipocalin 2 
DICER1  2.271   AP  Dicer 1, ribonuclease type III 
SLC8A1  -2.772  AP, FB  Solute  carrier  family  8  (sodium/calcium  exchanger), 
member 1 
TRIM54  3.982  AP, HT  Tripartite motif containing 54 
AKT1  3.209  AP, HT  v-akt murine thymoma viral oncogene homolog 1 
BCL2  -2.321  AP, HT  B-cell CLL/lymphoma 2 
MAPK8  -2.031  AP, HT, FB  Mitogen-activated protein kinase 8 
HMOX1  6.726  AP, HT, FB  Heme oxygenase (decycling) 1 
SOD2  -2.168  AP, HT, FB  Superoxide dismutase 2, mitochondrial 
SERPINE1  2.987  FB  Serpin peptidase inhibitor, clade E, member 1 
LMNA  2.426  FB  Lamin A/C 
BCL6  -4.261  FB  B-cell CLL/lymphoma 6 
TRDN  -2.075  FB  Triadin 
FN1  3.058  FB  Fibronectin 1 
SGCB  -2.442  FB  Sarcoglycan,  beta  (43kDa  dystrophin-associated 
glycoprotein) 
AR  -2.026  FB  androgen receptor 
RRM2B  -3.411  FB  Ribonucleotide reductase M2 B (TP53 inducible) 
NFATC1  2.015  HT  Nuclear  factor  of  activated  T-cells,  cytoplasmic, 
calcineurin-dependent 1 
TGFB1  2.1  HT  Transforming growth factor, beta 1 Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 106 of 119 
CDKN1A  8.625  HT  Cyclin-dependent kinase inhibitor 1A (p21, Cip1) 
ACE  2.242  HT  Angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 
MAPK3  2.748  HT  Mitogen-activated protein kinase 3 
PPP3CB  -2.307  HT  Protein phosphatase 3, catalytic subunit, beta isozyme 
MYH14  2.712  HT  Myosin, heavy chain 14, non-muscle 
MYH7  4.368  HT  Myosin, heavy chain 7, cardiac muscle, beta 
EGFR  -2.504  HT  Epidermal growth factor receptor 
MEF2D  2.588  HT  Myocyte enhancer factor 2D 
TTN  -2.72  HT  Titin 
SMTN  2.389  HT  Smoothelin 
NCF1  2.031  HT  Neutrophil cytosolic factor 1 
TIMP1  7.788  HT, FB  TIMP metallopeptidase inhibitor 1 
DES  2.286  HT, FB  Desmin 
APOE  6.703  HT, FB  Apolipoprotein E 
ATP2A2  -3.987  HT, FB  ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
CREB1  -2.851  HT, FB  cAMP responsive element binding protein 1 
* Only a portion of gene identified  was listed in this table. Function associations are based on Ingenuity 
Knowledge Base (Ingenuity Systems, Redwood City, CA). 
a AP, apoptosis; FB, fibrosis; HT, hypertrophy. 
 
 
Effects of SP supplementation on heart gene expression profiles of old and young mice. 
To determine the effects of dietary Se status on the cardiac gene expression of animals at 
different ages, we compared transcription profiles of 2-month-old mice fed SP (SPY) with 2-
month-old control (SDY) mice, 13-month-old mice fed with SP (SPO) with 13-month-old 
control  (SDO)  mice,  respectively.  Relative  to  aging  effects,  dietary  effects  on  the 
transcriptional profiles of the heart were moderate based on the number of changed genes 
alongside the magnitude of the changes shown. 
In  old  animals,  SP  supplementation  significantly  (P  <0.05,  FC  >1.2)  changed  the 
expression of 1685 cardiac genes (Up, 921; Down, 764), in which 88 genes had a FC > 2.0 or 
FC  <  -2.0  (Supplemental  table  3).    As  expected,  several  selenoprotein  encoding  genes 
including Sepw1, Gpx1, and Gpx3, which are functionally important in cellular oxidation-
reduction reactions, were significantly induced by SP (Supplement table 3).  PAGE analysis 
also indicated that oxidation reduction was the most enhanced biological process in SP-fed 
animals (Supplemental figure 1). Notably, multiple biomarker genes that were significantly 
induced in the aged hearts, including Lcn2, Timp1, Mhy7, and Spp1, were among those 
found  most  significantly  down-regulated  by  SP  (Supplemental  table  3,  Figure  5).  This 
prompted further comparative analysis on the effects of SP supplementation and aging on 
cardiac transcriptional profiles. Pathway analysis indicated a significant association between 
SP-regulated genes and increased carbohydrate metabolism and muscular cell development, 
while  functions  involved  in  immune  cell  trafficking,  cell  death,  cardiovascular  system 
development, and lipid metabolism were suppressed (Table 3).  
Upstream  regulator  analysis  (URA)  further  predicted  that  activation  of  Foxo1  and 
Foxo3, and the inhibition of Akt1, play important roles in gene expression changes related to 
SP supplementation (Figure 3). As shown in the figure, expression of Foxo1 and Foxo3, as 
well as many of its target genes, including biomarkers important in cardiovascular functions, Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 107 of 119 
were significantly altered by SP, indicating that transcriptional regulations by SP could be 
important in prevention of cardiac hypertrophy in old mice [32, 33]. 
 
Table 3. Biological functions related to genes differentially expressed by SP supplementation in old 
POLG mutator mice 
Functions Annotation
 a  P-Value  Molecules  Category  Activation 
b 
Chemotaxis of cells  3.33E-05  46  Cellular movement  -5.0 
Contractility of cardiac 
muscle 
5.82E-04  15  Cardiovascular system 
development and function 
-3.568 
Synthesis of lipid  2.72E-03  53  Lipid metabolism  -3.326 
Quantity of lymphocytes  6.85E-04  58  Hematological system 
development and function 
-3.085 
Quantity of leukocytes  1.35E-04  75  Tissue morphology  -3.023 
Quantity of b lymphocytes  2.63E-03  30  Humoral immune 
response 
-2.919 
Proliferation of immune 
cells 
7.30E-04  60  Cellular growth and 
proliferation 
-2.891 
Adhesion of immune cells  5.26E-03  28  Immune cell trafficking  -2.785 
Mobilization of cells  1.20E-03  10  Cellular movement  -2.774 
Inflammatory response  7.58E-04  54  Inflammatory response  -2.65 
Migration of phagocytes  1.67E-03  24  Immune cell trafficking  -2.474 
Migration of phagocytes  1.67E-03  24  Inflammatory response  -2.474 
Cell movement of 
phagocytes 
8.02E-04  43  Inflammatory response  -2.449 
Cell viability  9.18E-03  91  Cell death and survival  6.415 
Transactivation  1.02E-03  56  Gene expression  3.571 
Phosphorylation of l-
amino acid 
1.35E-02  17  Post-translational 
modification 
3.56 
Differentiation of 
embryonic cells 
6.48E-04  21  Cellular development  3.441 
Mitogenesis  8.47E-03  18  Cell cycle  2.813 
Expansion of cells  1.29E-02  24  Cellular growth and 
proliferation 
2.704 
Antiapoptosis  1.75E-04  26  Cell death and survival  2.646 
a Functions analysis by IPA (Ingenuity Systems, Redwood City , CA). 
b Predicted activation based on Z-score calculated by IPA, where a positive score predicts an increased 
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Figure  3.  Transcription  factors  and  targets  genes  regulated  by  SP  in  old  mice.  Upstream 
regulator analysis (URA) is based on expected causal effects between upstream regulators and targets; 
the expected causal effects are derived from the literature compiled in the IKB. The direction of 
change is the gene expression in the experimental samples relative to control. If the direction of 
change is consistent with the literature, URA predicts that the upstream regulator is more active in the 
experimental sample than in the control (Orange); if mostly inconsistent with the literature (anti-
correlated with the literature), IPA predicts that the upstream regulator is suppressed (Blue). The 
color of target genes (nodes) in the pictures shows the expression changes (Red, Up; Green, Down) 
detected in this study.  
 
In young mice, 660 heart genes were identified as significantly changed (Up, 273; Down, 
387) by SP, but only 8 genes had a FC > 2.0 or FC < -2.0, including Sepw1 (Supplemental 
table 4). The small number of changed genes and moderate FCs indicate the effects of dietary 
Se status on cardiac transcription profiles of young mice is relatively small compared to those 
in old mice. Transcription factor analysis, however, also indicated Foxo3 was activated by SP 
supplementation as in old animals (Supplemental figure 2). Biological functions significantly 
associated with SP-regulated genes in young animals are shown in (Table 4), where several 
functions related to cell survival and cancer were decreased. 
SP supplementation mitigates age-related cardiac transcriptional changes. To directly 
evaluate the effects of SP on aging-regulated genes, we compared the expression changes of Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 109 of 119 
these genes in response to aging and SP supplementation. Among 1943 genes that were 
significantly changed by age, 1356 (~70%) were regulated in the opposite direction by SP 
(Figure 4A). Of these, 262 genes were significantly (P < 0.05, FC >1.2) changed by diet in 
the reverse direction to the effects of aging (Figure 4B, details in Supplemental table 5). The 
counteractive effects of SP on aging-related transcriptional changes are also apparent when 
comparing  the  biological  functions  that  are  significantly  induced  by  aging  with  those 
suppressed by SP where many overlaps between age-increased functions and SP-decreased 
functions  including  inflammatory  response,  heart  contraction,  cell  viability,  and  lipid 
metabolism were observed (Table 5). 
 
Table  4.  Biological  functions  related  to  genes  differentially  expressed  by  SP  supplementation  in 
young POLG mutator mice 
Functions Annotation
 a  P-Value  Molecules  Category  Activation 
b 
Cell viability of tumor cell 
lines 
1.39E-02  40  Cell death and survival  -2.315 
Tumorigenesis of cells  1.51E-02  15  Cancer  -2.299 
Hyperplasia of epidermis  1.45E-02  5  Cancer  -2.219 
Cell viability of blood cells  1.46E-02  19  Cell death and survival  -2.195 
Transformation of blood 
cells 
3.29E-03  5  Cancer  -2.156 
Size of embryo  1.39E-02  23  Embryonic development  -2.101 
Transactivation  4.48E-04  44  Gene expression  -2.092 
Cell transformation  3.62E-03  34  Cancer  -2.086 
Transmigration of antigen 
presenting cells 
3.45E-03  4  Immune cell trafficking  -2.0 
Processing of RNA  2.83E-04  24  RNA post-transcriptional 
modification 
2.0 
a Functions analysis using IPA (Ingenuity Systems, Redwood City , CA). 
b Predicted activation based on Z-score calculated by IPA, where a positive score predicts an increased 
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Figure 4. Effects of SP supplementation on the expression of age-regulated genes in old POLG 
mice: A) 1943 genes that changed by aging were displayed. The fold change of age FC_Age and diet FC_SP 
are shown in y-axis and x-axis, respectively. Red dots represent genes significantly different between the SP-
supplemented group and old control group (P<0.05, FC >1.2). B) Unsupervised hierarchical clustering of the 
expression profiles from old and young animals.  Age-regulated genes were significantly and oppositely altered 
by SP in old POLG mice. In the heatmap, normalized gene expressions were shown in colors that reflect the 
expression changes compared with mean intensity of each gene transcript, where blue, red or yellow colors 
represent decreased, increased or no change in the level of expression intensity, respectively. The dendrogram 
on the top reflects the extent of similarity of expression profiles between arrays, while the dendrogram on the 
left side represents the changes of expression patterns of individual genes across the array.  
 
Table  5.  Top  biological  functions  significantly  associated  with  genes  induced  by  age  or  genes 
suppressed by SP
 * 
Function 
annotations  
Molecules  p-Value  Category  Z-score 
Functions related to age-induced genes 
Viral Infection  159  7.33E-06  Infectious disease  7.202 
Chemotaxis of 
phagocytes 
42  2.00E-07  Inflammatory response  4.799 
Phagocytosis  40  1.37E-07  Inflammatory response  4.195 
Organization of 
cytoplasm 
142  1.25E-07  Cellular assembly and 
organization 
3.956 
Inflammatory 
response 
92  1.03E-10  Inflammatory response  3.83 
Fibrogenesis  57  1.28E-08  Tissue development  3.082 
Contraction of 
heart 
26  6.00E-06  Cardiovascular system 
development and function 
2.897 
Release of fatty 
acid 
27  3.10E-06  Lipid metabolism  2.752 
Growth of tumor  49  2.50E-06  Cancer  2.716 Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 111 of 119 
Antiapoptosis  29  1.36E-04  Cell death and survival  2.621 
Metabolism of 
protein 
86  3.08E-05  Protein synthesis  2.596 
Functions related to SP-suppressed genes 
Cell viability  89  2.55E-04  Cell death and survival  -5.862 
Cell movement of 
tumor cell lines 
57  1.02E-04  Cellular movement  -4.823 
Proliferation of 
tumor cell lines 
89  5.92E-03  Cellular development  -4.415 
Leukocyte 
migration 
65  8.16E-04  Cellular movement  -3.587 
Contractility of 
cardiac muscle 
15  5.82E-04  Cardiovascular system 
development and function 
-3.568 
Synthesis of lipid  53  2.72E-03  Lipid metabolism  -3.326 
Transcription  141  1.86E-05  Gene expression  -3.005 
Inflammatory 
response 
54  7.58E-04  Inflammatory response  -2.65 
Chemotaxis of 
mononuclear 
leukocytes 
16  4.19E-03  Inflammatory response  -2.645 
Contraction of 
heart 
17  1.29E-03  Organ morphology  -2.425 
*Predicted  activation  based  on  Z-score  calculated  by  IPA,  where  a  positive  score  predicts  an  increased 
activity while a negative score indicate a suppressive effect. 
 
Validation  of  the  microarray  results.  To  perform  an  independent  validation  of  the 
microarray data, we used quantitative RT-PCR and Western blot methods for a subset of 
genes  that  were  significantly  changed  by  age  as  well  as  by  SP  supplementation  in  old 
animals. These genes were selected based on their biological connections to the development 
of cardiovascular  diseases  and  their significance in  the  expression change  on  microarray 
results.  Similar  FCs  were  obtained  for  the  effects  of  SP  and  aging,  with  RT-PCR  and 
microarray analysis on the selected genes as shown in Figure 5. Age-related increases in 
expression  of  Serpine1  (serine  protease  inhibitor  1),  Myh7,  Spp1,  Timp1  and  Trim54 
(tripartite motif-containing 54), which were significantly suppressed by SP in old POLG 
mice as determined by microarray analysis, were confirmed by RT-PCR (Figure 5A). Age-
related decrease of Gpx1 and Selh, two genes important in cellular oxidation and reduction 
process, were induced by SP in the heart (Figure 5A). The effects of aging and SP on the 
expression of Lcn2 and Snca (synuclein, alpha), both involved in cardiomyocyte apoptosis 
were also confirmed by RT-PCR (Figure 5). The increased expression of Foxo1 and Foxo3, 
two transcription regulators important in cardiac and skeletal muscle remodeling, was also 
confirmed in old animals fed with SP (Figure 5B). Western analysis indicated that the protein 
level  of  MYH7  (MHC-β),  a  molecular  biomarker  of  cardiac  hypertrophy  [34]  ,  was 
significantly decreased by SP in old POLG mice (Figure 5C).  Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 112 of 119 
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Figure 5. Gene expression change validation. A) Comparison of microarray and RT-qPCR results 
on the effects of aging and SP on select genes. Values represented are least square means ± SEM; n = 
7. Selected genes were: Lcn2 = lipocalin 2; Selh = sSelenoprotein H; Snca = synuclein, alpha; Gpx1 = 
glutathione peroxidase 1; Serpine1 = serine (or cysteine) peptidase inhibitor, clade E, member 1; 
Myh7  =  myosin,  heavy  polypeptide  7,  cardiac  muscle,  beta;  Spp1  =  secreted  phosphoprotein  1; 
Timp1 = tissue Inhibitor of metalloproteinase 1; Trim54 = tripartite motif-containing 54. B) Effects of 
SP on the expression of Foxo1 and Foxo3 in old animals. C) Effects of SP on the protein level of 
MYH7 in the heart of old POLG mice. 
* indicates P < 0.05, ** indicates P < 0.01. Student’s t-test. Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 113 of 119 
DISCUSSION:                          
The  mechanisms  that  connect  aging  and  cardiovascular  disease  are  complicated,  but 
accumulating  evidence  indicates  that  oxidative  stress  and  activation  of  inflammatory 
pathways  during  aging  play  a  central  role  [35,  36].  By  comparing  the  genome-wide 
transcriptional  profiles,  we  investigated  the  effects  of  aging  on  cardiac  gene  expression 
profiles as well as the preventive potential of dietary supplementation of selenium-enriched 
yeast  (SP),  a  popular  supplement  for  antioxidant  effects,  on  age-related  transcriptional 
alterations in POLG mutator mice. 
The  oxidative  stress  theory  of  aging  postulates  that  reactive  oxygen  species  (ROS) 
induce  a  variety  of  macromolecular  oxidative  modifications,  and  accumulation  of  such 
oxidative damage is a primary causal factor in the aging process [37]. Previous studies have 
indicated the associations between heart aging and impaired resistance to oxidative stress [5, 
6]. Induction of stress response genes such as GADD45α and β was found decreased in aged 
hearts, where the expression of several antioxidant genes including Gpx4, Peroxiredoxin 1, 
Peroxiredoxin 2, Sod1 and Sod2 was also significantly lower than that of young mice [6].   
In  the  present  study,  age-related  expression  changes  on  antioxidant  genes  were 
confirmed, as indicated by the decreased expression of Gpx 1 (FC = -2.3) and Sod2 (FC= - 
2.2) in old heart (Supplemental table 1). These findings indicate that the potential response to 
stress-induced injury is compromised in aged hearts. Given that many selenoproteins perform 
key  antioxidatnt  functions,  it  was  not  surprising  to  note  increased  expression  of  genes 
encoding SepW1, Gpx1, and Gpx3 in response to SP-supplemented diet (Supplemental table 
3).  The  increased  expression  of  genes  encoding  other  proteins  with  antioxidant  activity, 
namely Sod1 and Peroxiredoxin 6, may be explained by the fact that thioredoxin reductase 
(TxR),  a  selenium-dependent  enzyme,  is  known  to  regulate  Sod1  activity,  whereas 
thioredoxin, in its reduced form, regulates the expression of peroxiredoxins [38, 39] .   
Another hallmark of aging  is  the increase in  inflammatory  responses  with  age [30].  
Given the systemic nature of the immune system, it is reasonable to suggest that changes with 
age in inflammatory and/or immune response would have an effect on different tissues that 
could be detected as common molecular signatures of aging. Inflammatory processes have 
been  associated with  various age-related diseases,  such  as  Alzheimer’s disease, diabetes, 
cancer, and sarcopenia [40]. Consistent with this hypothesis, the results of the current study 
indicate  that  age-regulated  genes  were  significantly  associated  with  induced  biological 
pathways that are important in cellular immune and inflammatory responses, such as IL-8 
signaling,  acute  phase  response  signaling,  NF-κβ  activation,  and  the  complement  system 
(Figure 2). On the other hand, function-association analysis suggested a suppressive effect of 
SP supplementation on genes involved in multiple immune and inflammatory responses in 
old hearts (Table 3), while this effect was not apparent in the young animals. 
Along with the partial counteractive effects of SP supplementation on age-associated 
gene expression patterns shown in the pathway analysis, this study also compared the effects 
of aging and SP on the expression of biomarker genes that are important in cardiomyocyte 
apoptosis,  myocyte hypertrophy and cardiac fibrosis  and which are frequently  associated 
with functional changes in old hearts [2].  Cardiomyocyte apoptosis plays a critical role in the 
progression  of  heart  failure.  For  example,  in  patients  with  end-stage  cardiomyopathy  in Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 114 of 119 
dilated and ischemic heart disease, loss of cardiomyocytes due to apoptosis is directly related 
to the progression of cardiac dysfunction [41-43].  In this study, the expression of many 
genes that are functionally involved in myocyte apoptosis was significantly altered by age, 
including Lipocalin 2 (Lcn2) (Table 2). Lcn2 is an adipose-derived proinflammatory marker 
that has been associated with insulin resistance and obesity-related metabolic disorders [44, 
45]. Lcn2 may mediate the innate immune responses in the pathogenesis of heart failure [46]. 
Compared with young heart, Lcn2 expression was increased more than thirty times in old 
POLG mice, while SP significantly suppressed its expression in the heart of old POLG mice 
(Figure 5).   Similarly, several well known biomarkers related to cardiomyocyte hypertrophy, 
such as Myh7, were significantly up-regulated in old animals (Table 2).  Myh7 encodes the 
beta heavy chain subunit of cardiac myosin and is expressed predominantly in the heart. 
Changes in the relative abundance of this protein and the alpha heavy subunit of cardiac 
myosin correlate with the contractile velocity of cardiac muscle. Mutations in this gene are 
associated with moderate to severe hypertrophy [34, 47]. Decreased expression of Myh7 in 
old animals fed SP (Figure 5) suggests optimized dietary Se may be beneficial in preventing 
age-related cardiac hypertrophy.  
Progressive fibrosis is another hallmark of aging in various organs. Increased fibrosis is 
a  major  determinant  of  increased  myocardial  stiffness,  which,  together  with  impaired 
relaxation, creates the basis for the development of diastolic dysfunction [48]. Many genes 
related to heart fibrotic remodeling were regulated in old POLG mice (Table 2), in which 
serpin peptidase inhibitor, clade E, member 1(Serpine1) and TIMP metallopeptidase inhibitor 
1 (Timp1) are two extensively studied biomarkers for cardiac fibrosis. Serpine 1, also known 
as plasminogen activator inhibitor type 1 (Pai-1), encodes a member of the serine proteinase 
inhibitor (serpin), which plays significant roles in regulation of fibrosis by inhibiting the 
tissue collagenolytic activities and by protecting matrix proteins from proteolytic degradation 
[49].  The  increased  expression  of  this  potent  inhibitor  in  vivo  suppresses  the  normal 
fibrinolytic  system  and  creates  a  prothrombotic  state,  resulting  in  pathological  fibrin 
deposition followed by tissue damage [50]. The significantly higher expression of Serpine1 
in  old  mice,  where  expression  of  this  gene  was  significantly  decreased  by  SP,  probably 
indicates a beneficial effect of SP supplementation in maintaining heart function under stress 
conditions related with aging and POLG mutation.  Timp1 is a natural inhibitor of the matrix 
metalloproteinases (MMPs), which are involved in degradation of the extracellular matrix. 
Dysregulation of this gene has been related to dysfunction of many organs including heart, 
liver and kidney [51]. Aging caused significantly increased expression of the Timp1 gene in 
POLG mice, while its expression was significantly decreased by SP in old animals.  
Upstream regulator analysis in this study indicated that transcriptional activity of Foxo1 
and Foxo3, two members of the O subfamily of Forkhead/winged helix transcription factors 
(Foxo) were activated in old POLG mice (Figure 3).  Similar activation effect on Foxo3 was 
also predicted in young animals fed the SP-supplemented diet (Supplemental figure 3). Foxo 
transcription factors regulate key physiological functions including response to stress, cell 
differentiation, protein degradation and apoptosis [52, 53], and it plays important roles in 
regulating cardiac and skeletal muscle remodeling [54, 55]. Expression of either Foxo1 or Functional Foods in Health and Disease 2014; 4(3):98- 119                                                      Page 115 of 119 
Foxo3  in  cardiomyocytes  can  inhibit  agonist-induced  hypertrophy  growth  through 
suppressing the calcineurin/NFAT signaling cascade, while cardiac hypertrophy observed in 
Foxo3 null mutant mice [32]. These results suggest that modulation of transcription activity 
of Foxos play important roles in the effects related to SP supplementation. 
This study focused on the transcriptional profiling of young and old cardiac muscle from 
POLG mice fed either control or SP-supplemented diets over their lifetimes. Because the 
pathophysiology of aging is complex, it is likely that a detailed analysis of gene expression 
profiles  in  multiple  tissues  will  reveal  both  tissue-specific  and  general  patterns.  One 
limitation of this study is that POLG mutator mice, a premature aging model, display aging 
phenotypes much earlier than normal mice. As a result, its transcriptional response to SP 
supplementation  could  be different  from what  may  occur in  normal  mice over  a normal 
lifespan.  A  similar  experiment  using  wild-type  animals  would  be  of  interest  to  establish 
whether these observations hold true against a normal genetic background.  
 
CONCLUSIONS: 
In summary, the results of this study indicate that SP supplementation can partially attenuate 
the  effects  of  aging  on  cardiac  transcriptional  profiles  in  POLG  mutator  mice,  and  this 
protective  effect  may  be  mediated  through  several  mechanisms.  Firstly,  through  its 
involvement in antioxidant systems, SP supplementation induces the expression of genes 
important in stress resistance, a function usually compromised in old animals. Secondly, SP 
supplementation  suppressed  the  expression  of  genes  that  are  involved  in  age-dependent 
inflammatory and immune responses, which may prevent tissue damage caused by chronic 
inflammatory states  in  aged animals.  More specifically, SP supplementation significantly 
suppressed  the  expression  of  age-induced  genes  that  are  functionally  related  to 
cardiomyocyte  apoptosis,  hypertrophy,  and  fibrosis,  probably  by  regulating  the 
transcriptional activity mediated by Foxo transcription factors. Taken as a whole, the data 
from  the  present  study  demonstrate  that  dietary  supplementation  with  selenium-enriched 
yeast may ameliorate, at a transcriptional level, the effects of aging on cardiac function in old 
POLG mice. If similar effects hold true in relation to human heart, the health implications 
could be of major benefit from the perspective of geriatric health and well-being.   
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